Timeliness and Accuracy of Reporting Preliminary Blood Culture Results: A College of American Pathologists Q-Probes Study of 65 Institutions.
Reporting preliminary blood culture results presents challenges not present in the handling of other types of critical results. Unlike most critical values, which are reported soon after specimen collection, blood culture results may be delayed for many hours or even days. Reporting preliminary positive blood cultures requires both extra processing (preparing Gram smear) and results interpretation (reading Gram smear) before critical results can be reported. With continuous-monitoring blood culture systems, a positive result may occur at any time of day or night. However, laboratory staff able to process blood cultures and interpret Gram stain results may not always be present when a positive blood culture is initially detected. (17) Furthermore, careful preparation and accurate interpretation of the Gram stain is vital to avoid errors that may lead to inappropriate treatment. (18) Also, particularly at night, the provider who ordered a blood culture may no longer be primarily responsible for the patient's care, so that reaching an accountable clinical staff member who can receive and act on results may be another potential obstacle affecting timeliness of reporting results.
Because of the established impact on outcomes associated with timely and accurate processing and reporting of preliminary blood culture Gram stain results, this study aimed to establish benchmarks for laboratories to apply and assess performance of this critical test.
This observational study was conducted according to the Q-Probes format as previously described, which involved laboratories that subscribe to and participate in the program. (19) Instructions and data collection materials are provided by and returned to the College of American Pathologists by a specified time. After data analysis, subscribers receive an individual detailed report about their performance on quality indicators benchmarked against other participants. The range of performance among participants, summary data analysis of significant associations with demographics, and practice variables and critique are reported to each participating laboratory.
Participants were instructed to collect information on 100 consecutive positive blood culture cases or for 90 days, whichever came first. For each positive blood culture, patient locations (inpatient, outpatient, or emergency department) where the specimen was obtained were recorded, as well as patient locations when results were reported. Date and time of 4 processing events were recorded: (1) initial detection time (instrument signal or alarm), (2) Gram stain processing completed, (3) Gram stain microscopic examination completed and results ready to be reported, and (4) results successfully reported to appropriate clinical staff. The number of contacts or other separate actions required to complete final notification was collected. Finally, Gram stain and final culture results were recorded as one or more morphologic types that included gram-positive cocci, gram-positive bacilli, gram-negative cocci, gram-negative bacilli, and fungi.
Participants also provided information about various laboratory practices that potentially could affect reporting timeliness. These variables included blood culture system used; criteria, if any, for blood culture processing timeliness goals; type of personnel processing blood cultures during various times and days of the week; and locations where blood cultures are processed.
Cases involving a positive blood culture signal with negative culture, with negative preliminary Gram stain (no organisms identified), or when preliminary Gram stain was not performed were excluded. Cases were also excluded in which, by policy, notification of results from preliminary blood culture Gram stains was not required (eg, autopsy, repeat positives).
Participants also provided institutional demographic information that included occupied bed size, government affiliation, location, and type of institution, as well as accreditation and inspection status by the College of American Pathologists and the Joint Commission.
Data were tabulated and analyzed by the biostatistics department of the College of American Pathologists. A 2-phase approach was used to analyze the participant turnaround times. Individual associations between the turnaround times and the demographic and practice variables were analyzed using Kruskal-Wallis tests for discrete-valued independent variables and regression analysis for the continuous independent variables. Variables with significant associations (P <.10) were then included in a forward-selection multivariate regression model. A level of .05 was used for statistical significance. All statistical analyses were performed using SAS v9.2 (SAS Institute, Cary, North Carolina).
A total of 65 institutions submitted data involving 5108 positive blood cultures. One laboratory was excluded from analysis of turnaround time because of lack of complete data. Demographic diversity among participants is shown in Table 1. Most participants (60 of 65; 92.3%) were located in the United States, with 2 each from Canada and Saudi Arabia and 1 from Brazil. Within the last 2 years the College of American Pathologists had inspected 56 of 63 participating laboratories (88.9%) and the Joint Commission had conducted laboratory inspections at 11 of 63 (17.5%).
Of 56 laboratories that reported the type of blood culture method used, all used continuous monitoring systems. Most (51 of 56; 91.1%) blood culture systems were located in the microbiology laboratory section; 3 were located in the laboratory accessioning area, 1 in the core laboratory, and 1 in an off-site laboratory. Among 56 laboratories, 40 (71.4%) reported processing positive blood cultures 24 hours a day and 7 days per week. Among the remaining 16 laboratories, 8 processed positive blood cultures 7 to 9 hours per day and 8 processed positive blood cultures 14 to 18 hours per day. Among 56 laboratories, positive blood culture Gram stains were not performed by 5 laboratories (8.9%) and 6 laboratories (10.7%) during the weekday and weekend evening shifts, respectively. Eleven laboratories (19.6%) did not perform Gram stains during weekday or weekend night shifts. Preliminary testing on positive blood cultures, other than Gram staining, was done by 18 of 58 reporting laboratories (31.0%). Of these 18, two-thirds started testing after reporting Gram stain results, 1 before, and the remaining 5 variably began testing either before or after.
Gram stains were nearly always prepared in a laboratory's microbiology section, with 56 of 57 (98.2%) processed there during the day shift, 53 of 54 (98.1%) on weekday evening shifts, 50 of 53 (94.3%) on weekend evening shifts, and 43 of 47 (91.5%) during night shifts. In addition, Gram stains were nearly always read in a laboratory's microbiology section, with 54 of 56 Gram stains (96.4%) read there during the day shift, 44 of 50 (88.0%) during weekday evening shifts, 43 of 49 (87.8%) during weekend evening shifts, and 34 of 43 (79.1%) during night shifts. It was more common for microbiologists to prepare and read Gram stains during the day shift, whereas general medical technologists most often prepared and read Gram stains during the evening and night shifts (Table 2).
Among 5085 positive blood cultures, 2843 (55.9%) were collected from inpatients, 1951 (38.4%) from the emergency department, and 291 (5.7%) from outpatients. Information about patient location at the time of reporting results was available for 4976 blood cultures, of which 4236 (85.1%) were reported to inpatient locations and the remaining 740 (14.9%) to outpatient locations.
Timeliness of Reporting Blood Culture Results
Among all institutions, the median time from when the blood culture system produced a positive signal until preliminary Gram stain results were reported was 45 minutes. Within this time interval, preparing the Gram stain took the longest amount of time, followed by reading the Gram stain, then notification (Table 3).
The median overall time (37 minutes) among the 40 laboratories that process blood cultures continuously on a 24 hours per day, 7 days per week schedule was statistically different from the median turnaround time of 124 minutes for 15 laboratories that reported another processing schedule (P =.003). Likewise, for laboratories that continuously processed blood cultures on a 24-hour schedule, the median time required to finish processing Gram stains was significantly shorter (21 minutes) compared with the 14 laboratories that did not continuously process blood cultures (67 minutes), P =.03 (Table 4).
The time from initiating to completing notification of preliminary blood culture results was significantly longer for outpatient locations during weekday evening shifts (P =.002) and weekend night shifts (P =.02). Other factors, including use of timeliness goals, performing additional preliminary testing other than Gram stain, type of staff who prepare or read Gram stains, staff notified (nurse, primary caregiver), shift, and day of week (weekday, weekend), showed no statistical differences in timeliness of reporting results.
A total of 27 of 56 laboratories (48.2%) reported using a timeliness goal for time from initial instrument signal to notification; goals were used by 24 of 40 laboratories (60.0%) with continuous processing and notification practices compared with only 3 of 16 laboratories (18.8%) that did not continuously process positive blood cultures. Turnaround time goals were set at less than 30 minutes for 4 laboratories, less than 60 minutes for 19, and between 105 and 180 minutes for the remaining 4 laboratories. The median success rate with meeting goals was 80.9% (middle 80% range = 41%-96%). In addition, 11 of 56 laboratories (19.6%) reported using another turnaround time goal, which was from time of Gram stain completion to notification of results; for this goal, targets were set at 15, 20, and 30 minutes for each of 3 labs and 60 minutes for the remaining 8. The median compliance rate for this goal was 95.5% (middle 80% range = 85.9%-100%) for 10 reporting laboratories. Among the 39 participants that continuously processed positive blood cultures, the median time from initial positive to final notification was 35 minutes for the 24 participants that had defined turnaround time goals and 45 minutes for 15 participants who did not have goals. This difference did not reach statistical significance, P =.17. Finally, successful notification of positive blood cultures reached nearly 100% among all participants. Among 4650 notifications, 4359 (93.7%) were completed after 1 attempt, 197 (4.2%) after 2 attempts, and 63 (1.4%) after 3 attempts; 31 (0.7%) required more than 3 attempts.
Accuracy of Preliminary Gram Stain Results
Of 57 reporting participants, 55 (96.5%) reported routinely comparing preliminary blood culture Gram stain with final blood culture results. Concordance of preliminary Gram stain interpretation and final blood culture results from 5021 cases reported by participants is shown in Table 5. Gram stain interpretations were highly accurate, with only 1.2% discrepancies reported when compared with final culture results. The median discrepancy rate among 63 institutions was 1.0%, with 10th, 25th, and 75th percentiles of 3.2%, 2.0%, and 0%, respectively. Among the few discordant results between preliminary and final results, the most common errors were seen with misinterpreting gram-positive bacilli as gram-negative bacilli. Although 20.8% of mixed cultures showed discrepancies, 19 of 22 (86.4%) had one or more correct morphologies reported. The other 3 discrepancies with mixed cultures were reported to have gram-negative bacilli that were not identified by culture. There was no significant association between accuracy of preliminary results and shift or type of staff who prepared or read Gram stains.
This study examined 2 important quality measures of blood culture practice: timeliness and accuracy of preliminary Gram stain results. Both of these measures are important because blood culture results may immediately impact patient management, treatment, and outcomes. Few other microbiology tests are as important and have such immediate clinical impact as blood cultures. Previous studies have shown that timeliness of detecting bloodstream pathogens improves antimicrobial therapy, reduces costs, and decreases length of stay and patient mortality. (3-7,9-11) Timeliness and accuracy of preliminary blood culture results represent 2 important, evidence-based quality indicators that are closely linked to clinical outcomes.
Automation has substantially improved the ability to continuously monitor specimens to detect bacterial growth as soon as possible. These systems were used by 100% of study participants. Continuously monitoring blood culture systems detect more than half of bacteremias in 24 hours or less, and the vast majority (85%) in less than 48 hours. (20) Although certain advances in direct identification of microorganisms from blood cultures have been described, (12,13,21) the current diagnostic mainstay in routine laboratory practice is performing Gram smears from broth bottles that have signaled positive growth. The Gram stain provides a preliminary result that is vital to effectively managing patients with serious infections and has more clinical importance than does final culture results. (15) Communicating preliminary blood culture results to the patient's responsible health care provider, who is able to take action as soon as possible, is necessary to achieve the best clinical outcomes.
The median time to report preliminary Gram stain results for 63 participating laboratories ranged from 27 minutes (10th percentile) to more than 2.5 hours (90th percentile), with a 50th percentile of 45 minutes (Table 3). This wide range indicates substantial variation in laboratory performance. The most important factor shown in this study was the laboratory schedule used for processing blood cultures. Those laboratories that continuously processed positive cultures on a 24 hours per day, 7 days per week schedule performed significantly better. Continuously monitoring blood culture systems are designed to signal positive growth at any time. Therefore, the best turnaround time for reporting preliminary results will be attained by laboratories that are able to process cultures every day of the week throughout all shifts. Otherwise, the value of continuously monitoring blood culture systems is not fully realized. (17,22) Nevertheless, about 29% of participating laboratories reported processing blood cultures on an interrupted schedule so that processing and reporting positive blood cultures were delayed during certain times, generally on the weekend and/or at night. In this study, use of continuously monitoring blood culture technology was found to be suboptimal among some laboratories. Because of the importance of rapidly reporting positive blood cultures, alternative methods such as telepathology (23) or call-back arrangements may be considered when qualified laboratory staff are unavailable to immediately examine preliminary blood culture Gram smears. For example, an experienced technologist might be assigned on-call responsibility to read Gram smears either by on-site examination or remotely using digital imaging technology.
There was no significant association between timeliness goals or type of personnel who process blood cultures and the turnaround time for reporting preliminary blood culture results. However, reporting results on weekday evening and weekend night shifts took significantly longer than at other times, presumably because of variation in provider availability during certain times of the day. Although not statistically significant, there was a trend toward faster reporting times among the 59% of participants that had established turnaround goals when compared with other participants. Because of the important clinical significance of rapid processing and reporting of blood cultures, establishing and monitoring turnaround time goals should be considered for use as quality indicator. In addition, monitoring turnaround time goals has been shown to improve timeliness for other tests. (24)
It has been shown that delays in incubation of blood cultures after collection will increase time to initial detection of positive growth and decrease timeliness of making changes in antimicrobial therapy. (22,25,26) Although time from specimen collection to positive blood culture was not evaluated in this study, laboratories that do not process positive blood cultures continuously should ensure that there is no similar interruption in initially loading or incubating bottles that would further prolong overall time for detecting and reporting bacteremia.
Positive blood cultures are generally treated as critical values for reporting purposes. (16) Only about a third of laboratories report positive blood cultures directly to the patient's primary caregiver. In view of the Joint Commission's patient safety goal of reporting critical values to the patient's primary caregiver, it is presumed that nurses or other personnel notified by the laboratory of positive blood cultures notify the patient's primary caregivers. Although notification took, on average, about 1 minute longer among laboratories that directly notify primary caregivers of positive blood culture results, the overall time may be longer for laboratories that notify nurses or other personnel, who are then responsible for handing off this information to the patient's primary caregiver. It may be useful for laboratories that do not directly notify primary caregivers to check nursing or other staff procedures and practices to ensure that positive blood cultures are reported in a timely way to the patient's primary caregiver.
Organism morphology and Gram smear characteristics (positive/negative) were used as criteria to evaluate interpretive accuracy among all participants. Previous studies have used criteria that are more stringent to identify organisms such as Staphylococcus aureus or Candida albicans at the species level. (27,28) In this study participants did not report the extent of Gram smear reporting or criteria used for identifying discrepancies. Although newer molecular-based methods can rapidly and accurately identify a wide range of different microbial species directly from positive blood cultures, (12-14) the impact of this technology on management and outcomes of patients with bacteremia, beyond reporting preliminary Gram smear results, is yet to be determined. (29)
Previous studies have shown excellent concordance between preliminary blood culture Gram stain interpretations and final culture results. Rand and Tillan (18) reported a discrepancy rate of 57 of 8253 cultures (0.7%), but they excluded cultures growing fungi or any discrepancies that were considered less likely to lead to changes in antibiotic coverage. In another study, Sogaard et al (30) evaluated the accuracy of Gram smears in positive blood cultures from a regional laboratory. Mixed cultures, which occurred in 7% of initial samples, were excluded from analysis and gram-positive cocci were evaluated as 2 categories, based on clusters or chains/diplococcus morphology. Of the 5893 cases evaluated in the study of Sogaard et al, (30) the discrepancy rate was 1.0%. Finally, Uehara et al (6) reported 12 discrepancies (2.5%) among 482 cultures, which included 7.9% that were mixed. Uehara et al (6) applied stricter criteria to differentiate Staphylococcus from Streptococcus spp and bacteria in the Enterobacteriaceae family from Pseudomonas spp. Despite differences in study design, criteria used for discrepancies, and exclusions, the results of these 3 studies all show a high degree of accuracy for preliminary Gram smear results that is comparable with the median laboratory discrepancy rate of 1.0% and aggregate rate of 59 of 5021 cultures (1.2%) observed in a diverse group of 63 laboratories in the Q-Probes study. Discrepancies would have likely been slightly higher in this study if more strict criteria had been applied. The causes of discrepancies, such as clerical entry error versus interpretive error, were not evaluated in this or the other studies. However based on previous studies and variation of results among various organism morphologies, interpretive errors were probably the most important cause of discrepancies.
The highest discrepancy rate (20.8%) in this Q-Probes study was observed among mixed cultures. These cultures accounted for only 106 of 5021 positive blood cultures (2.1%). There were only 3 discrepancies involving mixed cultures in which at least 1 morphologic type from culture was not correctly identified. All 3 were read as gram-negative bacilli, of which 2 grew gram-positive bacilli. The next most common discrepancy (6.0%) was seen among gram-positive bacilli that were initially identified as gram-negative. This is consistent with other studies and has been partially explained by propensity of Bacillus sp and Clostridium sp to convert to gram-negative during later stages of growth as well as the tendency for these organisms to decolorize during the Gram stain procedure. (18,30) One of 13 (7.7%) gram-negative cocci were reported initially as gram-positive. In one previous study, misinterpretation of Acinetobacter sp as gram-positive in blood cultures was the most common cause for this type of discrepancy. (18) Finally, it should be noted that nearly all participants, 55 of 57 (96.5%), monitored accuracy of blood culture Gram stains as a quality indicator. This likely contributes, in part, to the high accuracy rates seen with preliminary Gram stain interpretations.
In summary, this Q-Probes study provides information about current blood culture practices and quality performance. In some laboratories, use of continuously monitoring blood culture technology is suboptimal when processing is performed only intermittently and not on all shifts. Otherwise, results from this study show excellent overall performance in the timeliness and accuracy of preliminary blood culture reporting practices. In addition to monitoring frequencies of solitary blood cultures and blood culture contamination rates, the timeliness and accuracy of preliminary blood culture results is another core laboratory quality performance indicator for assessing blood culture practices, which can now be evaluated based on benchmarks established by this Q-Probes study.
(1.) Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010; 38(2):367-374.
(2.) Ferrer R, Artigas A, Levy MM, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. J AMA. 2008; 299(19):2294-2303.
(3.) Barenfanger J, Graham DR, Kolluri L, et al. Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol. 2008; 130(6):870-876.
(4.) Cunney RJ, McNamara EB, Alansari N, Loo B, Smyth EG. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol. 1997; 50(12):1010-1012.
(5.) Inglis TJ, Hodge M, Ketharanathan S. A hospital-wide study of the impact of introducing a personal data assistant-augmented blood culture round. J Med Microbiol. 2008; 57(pt 1):43-49.
(6.) Uehara Y, Yagoshi M, Tanimichi Y, et al. Impact of reporting gram stain results from blood culture bottles on the selection of antimicrobial agents. Am J Clin Pathol. 2009; 132(1):18-25.
(7.) Schonheyder HC, Hojbjerg T. The impact of the first notification of positive blood cultures on antibiotic therapy: a one-year survey. APMIS. 1995; 103(1):37-44.
(8.) Bouza E, Sousa D, Munoz P, Rodriguez-Creixems M, Fron C, Lechuz JG. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis. 2004; 39:1161-1169.
(9.) Hautala T, Syrjala H, Lehtinen V, et al. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents. 2005; 25(4):329-333.
(10.) Lee CH, Kim J, Park Y, et al. Delta neutrophil index discriminates true bacteremia from blood culture contamination. Clin Chim Acta. 2014; 427:11-14.
(11.) Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 2003; 41(7):3119-3125.
(12.) Wang B, Jessamine P, Desjardins M, Toye B, Ramotar K. Direct mecA polymerase chain reaction testing of blood culture bottles growing Gram-positive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia. Diagn Microbiol Infect Dis. 2013; 75(1):37-41.
(13.) Lupetti A, Barnini S, Castagna B, Nibbering PH, Campa M. Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system. Clin Microbiol Infect. 2010; 16(7):986-991.
(14.) Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, Meier FA. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol. 2013; 51(4):1188-1192.
(15.) Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol. 2003; 41(1):495-497.
(16.) Howanitz PJ, Steindel SJ, Heard NV. Laboratory critical values policies and procedures: a College of American Pathologists Q-Probes Study in 623 institutions. Arch Pathol Lab Med. 2002; 126(6):663-669.
(17.) Savinelli T, Parenteau S, Mermel LA. What happens when automated blood culture instrument detect growth but there are no technologists in the microbiology laboratory? Diagn Microbiol Infect Dis. 2004; 48(3):173-174.
(18.) Rand KH, Tillan M. Errors in interpretation of Gram stains from positive blood cultures. Am J Clin Pathol. 2006; 126(5):686-690.
(19.) Howanitz PJ. Quality assurance measurements in departments of pathology and laboratory medicine. Arch Pathol Lab Med. 1990; 114(11):1131-1135.
(20.) Reisner BS, Woods GL. Times to detection of bacteria and yeasts in BACTEC 9240 blood culture bottles. J Clin Microbiol. 1999; 37(6):2024-2026.
(21.) Blaschke AJ, Heyrend C, Byington CL, et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis. 2012; 74(4):349-355.
(22.) Bengtsson J, Wahl M, Larsson P. Assessment of the BacT/Alert blood culture system: rapid bacteremia diagnosis with loading throughout the 24 h. Clin Microbiol Infect. 1998; 4:33-37.
(23.) McLaughlin WJ, Schifman RB, Ryan KJ, et al. Telemicrobiology: feasibility study. Telemed J. 1998; 4(1):11-17.
(24.) Novis DA, Walsh MK, Dale JC, Howanitz PJ. Continuous monitoring of stat and routine outlier turnaround times: two College of American Pathologists Q-Tracks monitors in 291 hospitals. Arch Pathol Lab Med. 2004; 128(6):621-626.
(25.) van der Velden LB, Vos FJ, Mouton JW, Sturm PD. Clinical impact of preincubation of blood cultures at 37 degrees C. J Clin Microbiol. 2011; 49(1): 275-280.
(26.) Kerremans JJ, van der Bij AK, Goessens W, Verbrugh HA, Vos MC. Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching. J Clin Microbiol. 2009; 47(11):3520-3523.
(27.) Murdoch DR, Greenlees RL. Rapid identification of Staphylococcus aureus from BacT/ALERT blood culture bottles by direct Gram stain characteristics. J Clin Pathol. 2004; 57(2):199-201.
(28.) Doymaz M, Yampierre C, Tarchini G, Riley W. Demonstration and utility of clustered pseudohyphae on Gram-stained smears from Candida albicans-positive blood cultures. Diagn Microbiol Infect Dis. 2010; 66(4):449-451.
(29.) Huang AM, Newton D, Kunapuli A, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia.Clin Infect Dis. 201; 57(9):1237-1245.
(30.) Sogaard M, Norgaard M, Schonheyder HC. First notification of positive blood cultures and the high accuracy of the gram stain report. J Clin Microbiol. 2007; 45(4):1113-111 7.
Ron B. Schifman, MD; Frederick A. Meier, MD; Rhona J. Souers, MS
Accepted for publication July 23, 2014.
From Diagnostics, Southern Arizona VA Healthcare System, University of Arizona College of Medicine, Tucson (Dr Schifman); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Meier); and the Department of Biostatistics, College of American Pathologists, Northfield, Illinois (Ms Souers).
The authors have no relevant financial interest in the products or companies described in this article.
Reprints: Ron B. Schifman, MD, Diagnostics, Southern Arizona VA Healthcare System, University of Arizona College of Medicine, 3601 S 6th Ave, Tucson, AZ 85723 (e-mail: Ronald.Schifman@VA.gov).
Table 1. Institutional Demographics Institutions Demographic No. % Institution type Private, nonprofit 38 62.3 Proprietary hospital 7 11.5 Nongovernmental, university hospital 5 8.2 Veterans hospital 3 4.9 Other governmental, nonfederal 2 3.3 County hospital 1 1.6 Department of Defense 1 1.6 Other, governmental, federal 1 1.6 Other, nongovernmental 1 1.6 Private, independent laboratory 1 1.6 State acute hospital 1 1.6 Occupied bed size 0-150 19 33.3 151-300 18 31.6 301-450 8 14.0 451-600 6 10.5 >600 6 10.5 Location City 32 52.5 Suburban 16 26.2 Rural 12 19.7 Other 1 1.6 Governmental affiliation Nongovernmental 52 85.2 Governmental, federal 5 8.2 Governmental, nonfederal 4 6.6 Table 2. Frequency of Personnel Type Who Prepare and Interpret Preliminary Blood Culture Gram Smears Day and Shift Gram Smear Preparation No. Microbiologist, No. (%) Weekday Day 57 41 (71.9) Evening 57 19 (33.3) Night 53 10 (18.9) Weekend Day 56 41 (73.2) Evening 56 19 (33.9) Night 54 10 (18.5) Day and Shift Gram Smear Preparation General Medical Laboratory Technologist, Technician/Other, No. (%) No. (%) Weekday Day 10 (17.5) 6 (10.5) Evening 27 (47.4) 11 (19.3) Night 35 (66.0) 8 (15.1) Weekend Day 10 (17.9) 5 (8.9) Evening 30 (53.6) 7 (12.5) Night 35 (64.8) 9 (16.7) Day and Shift Gram Smear Interpretation No. Microbiologist, No. (%) Weekday Day 57 44 (77.2) Evening 52 18 (34.6) Night 45 9 (20.0) Weekend Day 57 44 (77.2) Evening 51 18 (35.3) Night 45 9 (20.0) Day and Shift Gram Smear Interpretation General Medical Laboratory Technologist, Technician/Other, No. (%) No. (%) Weekday Day 10 (17.5) 3 (5.3) Evening 27 (51.9) 7 (13.5) Night 31 (68.9) 5 (11.1) Weekend Day 8 (14.0) 5 (8.8) Evening 28 (54.9) 5 (9.8) Night 31 (68.9) 5 (11.1) Table 3. Distribution of Median Institutional Turnaround Time for Blood Culture Processing Turnaround Time, min All Institutions Percentile No. 10th 25th Median 75th 90th Total turnaround time 63 27 32 45 73 158 Time to complete 61 10 17 25 50 161 Gram stain Time to read 61 3 5 7 11 21 Gram stain Time to initiate 61 1 2 3 5 12 notification Time to complete 62 0 1 2 3 6 notification Time from reading Gram 61 3 4 6 10 19 stain to completing notification Table 4. Distribution of Median Institutional Turnaround Time Stratified by Continuous and Intermittent Blood Culture Processing Schedules Turnaround Time, min Positive Blood Culture Processing Schedules Continuous Percentile No. 10th 25th Median 75th 90th Total turnaround time 40 23 30 37 57 101 Time to complete 39 61 40 21 15 10 Gram stain Time to read Gram stain 39 13 10 5 4 2 Time to initiate 39 10 5 2 1 1 notification Time to complete 39 5 3 1 0 0 notification Time from reading Gram 39 12 8 5 3 2 stain to completing notification Turnaround Time, min Positive Blood Culture Processing Schedules Intermittent Percentile No. 10th 25th Median 75th 90th Total turnaround time 15 40 51 124 178 395 Time to complete 14 15 34 67 191 519 Gram stain Time to read Gram stain 14 3 5 12 18 130 Time to initiate 14 3 3 5 12 22 notification Time to complete 14 1 1 2 3 26 notification Time from reading Gram 14 5 5 10 16 55 stain to completing notification Table 5. Preliminary Blood Culture Gram Smear-Culture Discrepancies Result Gram Stain Discrepancies With Final Culture Results No. (% of All, No. GNC GNR GPC GPR Total Cases) (%) Fungi 81 (1.6) 1 (1.2) 1 GNC 13 (0.3) 1 (7.7) 1 GNR 1373 (27.3) 11 (0.8) 2 2 4 GPC 3113 (62.0) 4 (0.1) 1 2 GPR 335 (6.7) 20 (6.0) 17 3 Mixed 106 (2.1) 22 (20.8) 3 Total 5021 59 (1.2) 2 19 6 6 Result Gram Stain Discrepancies With Final Culture Results Other Fungi GNC GNR GNR/GPC (2), GNR/GNC (1) GPC GPC/GPR (1) GPR Mixed [greater than or equal to] 1 correct morphology (19) Total Abbreviations: GNC, gram-negative cocci; GNR, gram-negative bacilli; GPC, gram-positive cocci; GPR, gram-positive bacilli.
|Printer friendly Cite/link Email Feedback|
|Author:||Schifman, Ron B.; Meier, Frederick A.; Souers, Rhona J.|
|Publication:||Archives of Pathology & Laboratory Medicine|
|Article Type:||Clinical report|
|Date:||May 1, 2015|
|Previous Article:||Impact of a Rapid Respiratory Panel Test on Patient Outcomes.|
|Next Article:||Sudden Cardiac Death Due To IgG4-Related Disease.|